DrugPatentWatch Database Preview
Details for Biologics License Application: 021810
» See Plans and Pricing
Summary for BLA: 021810
Tradename: | NOVOLOG MIX 50/50 |
Applicant: | Novo Nordisk Inc |
Ingredient: | insulin aspart protamine recombinant; insulin aspart recombinant |
Patents: | 10 |
Approval Date: | Nov 21, 2017 |
US Patents for BLA: 021810
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Novo Nordisk Inc | NOVOLOG MIX 50/50 | insulin aspart protamine recombinant; insulin aspart recombinant | INJECTABLE;SUBCUTANEOUS | 021810 | 001 | 2017-11-21 | Start Trial | Novo Nordisk A/S (Basgsvaerd, DK) | 2013-08-20 | DISCN | company | |
Novo Nordisk Inc | NOVOLOG MIX 50/50 | insulin aspart protamine recombinant; insulin aspart recombinant | INJECTABLE;SUBCUTANEOUS | 021810 | 001 | 2017-11-21 | Start Trial | Novo Nordisk A/S (Bagsvaerd, DK) | 2014-04-08 | DISCN | company | |
Novo Nordisk Inc | NOVOLOG MIX 50/50 | insulin aspart protamine recombinant; insulin aspart recombinant | INJECTABLE;SUBCUTANEOUS | 021810 | 001 | 2017-11-21 | Start Trial | Novo Nordisk A/S (Bagsvaerd, DK) | 2014-12-02 | DISCN | company | |
Novo Nordisk Inc | NOVOLOG MIX 50/50 | insulin aspart protamine recombinant; insulin aspart recombinant | INJECTABLE;SUBCUTANEOUS | 021810 | 001 | 2017-11-21 | Start Trial | Novo Nordisk A/S (Bagsvaerd, DK) | 2013-06-21 | DISCN | company | |
Novo Nordisk Inc | NOVOLOG MIX 50/50 | insulin aspart protamine recombinant; insulin aspart recombinant | INJECTABLE;SUBCUTANEOUS | 021810 | 001 | 2017-11-21 | Start Trial | Novo Nordisk A/S (Bagsvaerd, DK) | 2013-06-21 | DISCN | company | |
Novo Nordisk Inc | NOVOLOG MIX 50/50 | insulin aspart protamine recombinant; insulin aspart recombinant | INJECTABLE;SUBCUTANEOUS | 021810 | 001 | 2017-11-21 | Start Trial | Novo Nordisk A/S (Bagsvaerd, DK) | 2016-06-20 | DISCN | company | |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |